NeuroPace (NPCE) Market Capitalization (2021 - 2026)

NeuroPace has reported Market Capitalization for 6 years, with the latest figure at $544.8 million in Q2 2026.

• On a quarterly basis, Market Capitalization rose 47.98% year-over-year to $544.8 million in Q2 2026; TTM through Jun 2026 was $544.8 million, a 47.98% increase from a year earlier, with the FY2025 full-year figure at $518.4 million, up 53.68% from the prior year.
• Market Capitalization was $544.8 million for Q2 2026 at NeuroPace, up from $445.9 million in the prior quarter.
• The five-year high for Market Capitalization was $544.8 million in Q2 2026, with the low at $37.3 million in Q4 2022.
• Average Market Capitalization over 5 years is $277.6 million, with a median of $271.1 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Market Capitalization plunged 77.71% in 2022, then jumped 668.69% in 2023.
• Over 5 years, Market Capitalization stood at $37.3 million in 2022, then surged by 668.69% to $286.9 million in 2023, then grew by 17.59% to $337.3 million in 2024, then soared by 53.68% to $518.4 million in 2025, then grew by 5.08% to $544.8 million in 2026.
• The last three Market Capitalization figures came in at $544.8 million (Q2 2026), $445.9 million (Q1 2026), and $518.4 million (Q4 2025), per Business Quant data.